Center for Scientific Review; Notice of Closed Meetings, 79627-79628 [2024-22362]
Download as PDF
<![CDATA[
Federal Register / Vol. 89, No. 189 / Monday, September 30, 2024 / Notices
Dated: September 24, 2024.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2024–22291 Filed 9–27–24; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Recharter for the Council on Graduate
Medical Education
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services.
ACTION: Notice.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
Department of Health and Human
Services is hereby giving notice that the
Council on Graduate Medical Education
(COGME or Council) is rechartered.
DATES: The effective date of the renewed
charter is September 30, 2024.
FOR FURTHER INFORMATION CONTACT:
Shane Rogers, Designated Federal
Official (DFO), Division of Medicine
and Dentistry, Bureau of Health
Workforce, HRSA, 5600 Fishers Lane,
Room 15N142, Rockville, Maryland
20857; 301–443–5260; or srogers@
hrsa.gov.
SUPPLEMENTARY INFORMATION: COGME
makes recommendations to the
Secretary of Health and Human Services
and Congress on matters specified by
section 762 of the Public Health Service
Act. Issues addressed by COGME
include: (1) the supply and distribution
of physicians in the United States; (2)
current and future shortages or excesses
of physicians in medical and surgical
specialties and subspecialties; (3) issues
relating to internationalmedical school
graduates; (4) appropriate federal
policies with respect to the matters
specified in (1), (2), and (3) above,
including policies concerning changes
in the financing of undergraduate and
graduate medical education programs
and changes in the types of medical
education training in graduate medical
education programs; (5) appropriate
efforts to be carried out by hospitals,
schools of medicine, schools of
osteopathic medicine, and accrediting
bodies with respect to the matters
specified in (1), (2), and (3) above,
including efforts for changes in
undergraduate and graduate medical
education programs; and (6) deficiencies
in, and needs for improvements in,
existing databases concerning the
supply and distribution of, and
ddrumheller on DSK120RN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
17:51 Sep 27, 2024
Jkt 262001
postgraduate training programs for,
physicians in the United States and
steps that should be taken to eliminate
those deficiencies. Not later than
September 30, 2023, and not less than
every 5 years thereafter, COGME shall
submit a report on the recommendations
made by the committee to the Secretary
of Health and Human Services, and to
the Committee on Health, Education,
Labor, and Pensions of the Senate and
the Committee on Energy and
Commerce of the House of
Representatives. Additionally, COGME
encourages entities providing graduate
medical education to conduct activities
to voluntarily achieve the
recommendations of the Council;
develops, publishes, and implements
performance measures; develops and
publishes guidelines for longitudinal
evaluations; and recommends
appropriation levels for certain
programs under title VII of the Public
Health Service Act.
The renewed charter for COGME was
approved on September 18, 2024. The
filing date is September 30, 2024. The
recharter of COGME gives authorization
for the Council to operate until
September 30, 2026.
A copy of the COGME charter is
available on the COGME website at
https://www.hrsa.gov/sites/default/files/
hrsa/advisory-committees/graduatemedical-edu/cogme-charter.pdf. A copy
of the charter also can be obtained by
accessing the FACA database that is
maintained by the Committee
Management Secretariat under the
General Services Administration. The
website address for the FACA database
is https://www.facadatabase.gov/.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2024–22256 Filed 9–27–24; 8:45 am]
BILLING CODE 4165–15–P
79627
Person listed below in advance of the
meeting. The meeting can be accessed
from the NIH Videocast at the following
link: https://videocast.nih.gov/.
Name of Committee: Office of AIDS
Research Advisory Council.
Date: October 24, 2024.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: Report from the OAR Director;
Update on the Development of the NIH
Strategic Plan and Research Priorities for HIV
Research.
Place: Office of AIDS Research, Office of
the Director, NIH, 5601 Fishers Lane,
Rockville, MD 20852, (Virtual Meeting)
https://videocast.nih.gov/.
Contact Person: CAPT Mary Glenshaw,
Ph.D., M.P.H., OTR/L, Office of AIDS
Research, Office of the Director, NIH, 5601
Fishers Lane, Room 2E61, Rockville, MD
20852, (301) 496–0357, OARACinfo@nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page:
www.oar.nih.gov, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: September 24, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–22274 Filed 9–27–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director, National
Institutes of Health; Notice of Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Office of AIDS Research
Advisory Council.
The meeting will be held as a virtual
meeting and will be open to the public
as indicated below. Individuals who
plan to view the virtual meeting and
need special assistance or other
reasonable accommodations to view the
meeting, should notify the Contact
PO 00000
Frm 00127
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
E:\FR\FM\30SEN1.SGM
30SEN1
79628
Federal Register / Vol. 89, No. 189 / Monday, September 30, 2024 / Notices
ddrumheller on DSK120RN23PROD with NOTICES1
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Aging and
Neurodegeneration Integrated Review Group;
Clinical Neurodegeneration Translational
Neuroscience Study Section.
Date: October 24–25, 2024.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency, Bethesda, One
Bethesda Metro Center, Bethesda, MD 20814.
Meeting Format: In-Person Meeting.
Contact Person: Jordan M. Moore, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1002A1,
Bethesda, MD 20892, (301) 451–0293,
jordan.moore@nih.gov.
Name of Committee: Genes, Genomes, and
Genetics Integrated Review Group; Molecular
Genetics Study Section.
Date: October 24–25, 2024.
Time: 8:00 a.m. to 10:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Bethesdan Hotel, 8120
Wisconsin Avenue, Bethesda, MD 20814.
Meeting Format: In-Person Meeting.
Contact Person: Altaf Ahmad Dar, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 827–2680, altaf.dar@nih.gov
Name of Committee: Social and
Community Influences on Health Integrated
Review Group; Social Sciences and
Population Studies B Study Section.
Date: October 24–25, 2024.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Meeting Format: In-Person Meeting.
Contact Person: Kate Fothergill, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive Room 3142,
Bethesda, MD 20892, 301–435–2309,
fothergillke@mail.nih.gov.
Name of Committee: Surgical Sciences,
Biomedical Imaging and Bioengineering
Integrated Review Group; Imaging
Technology Development Study Section.
Date: October 24–25, 2024.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Guo Feng Xu, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5122,
MSC 7854, Bethesda, MD 20892, (301) 237–
9870, xuguofen@csr.nih.gov.
VerDate Sep<11>2014
17:51 Sep 27, 2024
Jkt 262001
Name of Committee: Brain Disorders and
Clinical Neuroscience Integrated Review
Group; Brain Injury and Neurovascular
Disorders Study Section.
Date: October 24–25, 2024.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Paula Elyse Schauwecker,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5201,
Bethesda, MD 20892, 301–760–8207,
schauweckerpe@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Neuromodulation and Imaging of Neuronal
Circuits.
Date: October 24–25, 2024.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Pablo Miguel Blazquez
Gamez, Ph.D., Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (301) 435–1042,
pablo.blazquezgamez@nih.gov.
Name of Committee: Cardiovascular and
Respiratory Sciences Integrated Review
Group; Pulmonary Vascular Disease and
Physiology Study Section.
Date: October 24–25, 2024.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Bradley Nuss, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4142,
MSC7814 Bethesda, MD 20892, 301–451–
8754, nussb@csr.nih.gov.
Name of Committee: Brain Disorders and
Clinical Neuroscience Integrated Review
Group; Clinical Neuroplasticity and
Neurotransmitters Study Section.
Date: October 24–25, 2024.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Suzan Nadi, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5217B,
MSC 7846, Bethesda, MD 20892, 301–435–
1259, nadis@csr.nih.gov.
Name of Committee: Infectious Diseases
and Immunology A Integrated Review Group;
Molecular and Structural Immunology Study
Section.
Date: October 24–25, 2024.
PO 00000
Frm 00128
Fmt 4703
Sfmt 4703
Time: 9:30 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Velasco Cimica, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, 6701 Rockledge Drive,
Bethesda, MD 20892, 301–594–1760,
velasco.cimica@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Biophysical, Physiological,
Pharmacological and Bioengineering
Neuroscience, and Vision.
Date: October 24–25, 2024.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Angela Monique Boutte,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Dr., Bethesda, MD
20892, (301) 594–0063, boutteam@
csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: September 24, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–22362 Filed 9–27–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request; Adolescent Brain &
Cognitive Development (ABCD)
StudySM—Audience Feedback Teams
(National Institute on Drug Abuse)
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
In compliance with the
Paperwork Reduction Act of 1995, the
National Institutes of Health (NIH) has
submitted to the Office of Management
and Budget (OMB) a request for review
and approval of the information
collection listed below.
DATES: Comments regarding this
information collection are best assured
of having their full effect if received
within 30-days of the date of this
publication.
SUMMARY:
E:\FR\FM\30SEN1.SGM
30SEN1
]]>Agencies
[Federal Register Volume 89, Number 189 (Monday, September 30, 2024)]
[Notices]
[Pages 79627-79628]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-22362]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose
[[Page 79628]]
confidential trade secrets or commercial property such as patentable
material, and personal information concerning individuals associated
with the grant applications, the disclosure of which would constitute a
clearly unwarranted invasion of personal privacy.
Name of Committee: Aging and Neurodegeneration Integrated Review
Group; Clinical Neurodegeneration Translational Neuroscience Study
Section.
Date: October 24-25, 2024.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency, Bethesda, One Bethesda Metro Center,
Bethesda, MD 20814.
Meeting Format: In-Person Meeting.
Contact Person: Jordan M. Moore, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1002A1, Bethesda, MD 20892, (301)
451-0293, [email protected].
Name of Committee: Genes, Genomes, and Genetics Integrated
Review Group; Molecular Genetics Study Section.
Date: October 24-25, 2024.
Time: 8:00 a.m. to 10:00 p.m.
Agenda: To review and evaluate grant applications.
Place: The Bethesdan Hotel, 8120 Wisconsin Avenue, Bethesda, MD
20814.
Meeting Format: In-Person Meeting.
Contact Person: Altaf Ahmad Dar, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 827-2680,
[email protected]
Name of Committee: Social and Community Influences on Health
Integrated Review Group; Social Sciences and Population Studies B
Study Section.
Date: October 24-25, 2024.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda,
MD 20814.
Meeting Format: In-Person Meeting.
Contact Person: Kate Fothergill, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive Room 3142, Bethesda, MD 20892, 301-435-
2309, [email protected].
Name of Committee: Surgical Sciences, Biomedical Imaging and
Bioengineering Integrated Review Group; Imaging Technology
Development Study Section.
Date: October 24-25, 2024.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Guo Feng Xu, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5122, MSC 7854, Bethesda, MD 20892, (301) 237-
9870, [email protected].
Name of Committee: Brain Disorders and Clinical Neuroscience
Integrated Review Group; Brain Injury and Neurovascular Disorders
Study Section.
Date: October 24-25, 2024.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Paula Elyse Schauwecker, Ph.D., Scientific
Review Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5201, Bethesda, MD 20892, 301-
760-8207, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Neuromodulation and Imaging of Neuronal Circuits.
Date: October 24-25, 2024.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Pablo Miguel Blazquez Gamez, Ph.D., Scientific
Review Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 435-1042,
[email protected].
Name of Committee: Cardiovascular and Respiratory Sciences
Integrated Review Group; Pulmonary Vascular Disease and Physiology
Study Section.
Date: October 24-25, 2024.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Bradley Nuss, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4142, MSC7814 Bethesda, MD 20892, 301-451-
8754, [email protected].
Name of Committee: Brain Disorders and Clinical Neuroscience
Integrated Review Group; Clinical Neuroplasticity and
Neurotransmitters Study Section.
Date: October 24-25, 2024.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Suzan Nadi, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5217B, MSC 7846, Bethesda, MD 20892, 301-435-
1259, [email protected].
Name of Committee: Infectious Diseases and Immunology A
Integrated Review Group; Molecular and Structural Immunology Study
Section.
Date: October 24-25, 2024.
Time: 9:30 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Velasco Cimica, Ph.D., Scientific Review
Officer, Center for Scientific Review, 6701 Rockledge Drive,
Bethesda, MD 20892, 301-594-1760, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Fellowships: Biophysical, Physiological, Pharmacological and
Bioengineering Neuroscience, and Vision.
Date: October 24-25, 2024.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Angela Monique Boutte, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Dr., Bethesda, MD 20892, (301) 594-0063,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: September 24, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-22362 Filed 9-27-24; 8:45 am]
BILLING CODE 4140-01-P
